alexa HRT-free Management Of Premature Andropause With Advanced Organ-specific Peptide Therapy
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

12TH ANNUAL CONFERENCE ON Nephrology & Urology
JULY 06-07, 2017 KUALA LUMPUR, MALAYSIA

Dmitry Klokol
Stellar Biomolecular Research, Germany
European Wellness Academy, Germany
Posters & Accepted Abstracts: J Nephrol Ther
DOI: 10.4172/2161-0959-C1-043
Abstract
Management of early andropause is one of the important issues in andrology. Early or premature andropause is associated with such symptoms as loss of libido and morning penile erection, erectile dysfunction, demonstration of low testosterone levels, and ultimately male infertility. Needless to mention that reduction of sexual hormonal expression plays a pivotal role in aging process. Genetics, previous illnesses, certain medical procedures, and environmental factors are the leading etiologic factors of premature andropause development. Premature andropause is often responsible for cognitive decline, dyslipidemia, diabetes, obesity, fatigue, and loss of muscle bulk. Biochemical signs of premature andropause are reduction of basal and free testosterone levels at 15% or more below normal range. Conventionally this condition is treated with testosterone replacement therapy. However, testosterone replacement may carry risk of cardiac hypertrophy, prostate hyperplasia and aggravate symptoms in men with prostate cancer. The objective of this study was to assess efficacy of biohormonal therapy using a combination of organ-specific peptides-extracts (Mito Organelles™, SBI, MF+, Germany) from hypothalamus, pituitary gland, adrenals, testicles and liver as a safer alternative to the testosterone replacement. The duration of the treatment is 4 months and does not require continuous prolonged drug intake. Organ-specific peptide therapy has high efficacy rate with no adverse reactions observed. Most of the patients had dramatic improvement of symptoms and increase of testosterone levels. None of the observed patients had need in further testosterone replacement. Obtained preliminary results are promising and such therapeutic approach needs further studies and evaluation of late results and outcomes.
Biography

Dmitry Klokol, upon completion of Medical Degree and further specialization in General Surgery has proceeded with PhD in Surgery in Institute of Emergency and Reconstructive Surgery and Post-doctoral study in the Field of Regenerative Medicine and Cell Therapy. He has vast clinical, academical and research experience in surgery, anti-aging, regenerative, complementary medicine and cell therapy. He has published more than 50 articles, 2 books and is a Member of the Editorial Board in one of American journals. At present, he is Head of Medical Advisory Board in International Biomolecular Research Company and Medical Director of European Wellness Centers.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords